Clinical Trials Browser

Osteosarcoma

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

Neoplasm Metastasis

Phase 2 Study

Advanced HER2 Negative Breast Carcinoma HRD+Breast Cancer

Microsatellite-stable Colorectal Cancer

Carcinoma, Non-Small-Cell Lung

Carcinoma, Renal Cell

Brain Neoplasms, Neoplasm Metastasis

Mesothelioma, Malignant, Mesothelioma

Multiple Myeloma

Colorectal Neoplasms

Recurrent Head and Neck Carcinoma

Advanced Renal Cell Carcinoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Dendritic Cell Sarcoma, Follicular, Histiocytic Sarcoma

Colonic Neoplasms

Astrocytoma, Glioblastoma, Gliosarcoma

Oropharyngeal Neoplasms

Lymphoma, Follicular

Glioblastoma

Breast Carcinoma In Situ

Lymphoma, Follicular

Leukemia, Myeloid, Acute

Rectal Neoplasms

Leukemia, Plasma Cell, Multiple Myeloma

Carcinoma, Renal Cell

Carcinoma, Hepatocellular

Pancreatic Neoplasms

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Prostatic Neoplasms

Diffuse Intrinsic Pontine Glioma

Hepatocellular Carcinoma Non-resectable

Rectal Neoplasms

Diabetes Mellitus, Insulin-Dependent, 12, Colorectal Neoplasms

Stomach Adenocarcinoma

Breast Neoplasms

Congenital Abnormalities, Lymphoma, Large B-Cell, Diffuse

Colorectal Neoplasms

Colorectal Neoplasms

Clinical Trials

Trastuzumab Deruxtecan for the Treatment of HER2+ Newly Diagnosed or Recurrent Osteosarcoma

Testing Obeticholic Acid for Familial Adenomatous Polyposis

Study of Chemotherapy Plus Ipatasertib for People With Solid Tumors With PTEN/AKT Mutations, A ComboMATCH Treatment Trial

A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic Cancer

Fluzoparib in Combination With or Without Camrelizumab for Homologous Recombinant Deficiency (HRD) HER2 Negative Advanced Breast Cancer

Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer

TOP 2301: Neoadjuvant Chemo for NSCLC

Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Stereotactic Body Radiation Therapy or Intensity Modulated Radiation/Proton Therapy in Treating Patients With Recurrent Head and Neck Cancer

ARCITECT

Pembrolizumab in Neoplasms or Lymphomas

ERASE-CRC

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Pre-operative Atezolizumab in Patients With Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma

Epcoritamab and Tazemetostat for the Treatment of Relapsed or Refractory Grade I-IIIa Follicular Lymphoma

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

Lenalidomide and Epcoritamab for the Treatment of Previously Untreated Follicular Lymphoma

A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia

Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer

IMPACT

Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma

Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

Therasphere® and Systemic Therapy for Patients With Hepatocellular Carcinoma That is High-risk

Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)

Lip-Re2

ICUREC

NEST-1

TORCH-G

Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)

Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma

RILUZOX-01

SIRIUS